CJC-1295 (No DAC) / Ipamorelin

Growth Hormone Signaling • Recovery • Body Composition Support

The CJC-1295 (No DAC) / Ipamorelin blend is a physician-prescribed growth hormone secretagogue combination designed to support natural growth hormone (GH) signaling through complementary, physiologic pathways. Rather than supplying exogenous hormone, this formulation stimulates the body’s own GH release while preserving normal feedback mechanisms and pulsatile rhythm.

CJC-1295 (No DAC) supports sustained GH signaling by extending receptor engagement without disrupting physiologic timing, while Ipamorelin provides targeted GH pulse stimulation with a favorable tolerability profile. Together, they create a balanced, non-suppressive approach to supporting recovery capacity, lean tissue preservation, metabolic efficiency, and sleep-associated repair.

Within structured wellness, longevity, and optimization frameworks, this combination is commonly utilized to reinforce recovery signaling, connective tissue resilience, and metabolic adaptability—without bypassing the body’s endogenous regulatory systems.

ASPN Insight

At ASPN, CJC-1295 (No DAC) / Ipamorelin is positioned as a foundational growth hormone signaling therapy, most often incorporated during restoration or optimization phases to support sleep quality, recovery efficiency, and long-term metabolic resilience under clinician supervision.

Prescription & Payment Notice

CJC-1295 (No DAC) / Ipamorelin is a prescription-only peptide therapy provided exclusively within ASPN’s clinician-guided programs due to its role in endocrine signaling and recovery support.

This therapy is prescribed by a licensed medical provider and dispensed through a U.S.-licensed compounding pharmacy in accordance with applicable state and federal regulations. ASPN does not manufacture, compound, or dispense prescription medications.

To ensure appropriate medical evaluation, protocol alignment, and individualized clinical oversight, orders for prescription products are subject to a temporary payment authorization hold at checkout. Charges are finalized only after prescription approval and clinical clearance are completed.

This process supports safety, regulatory compliance, and personalized care as part of ASPN’s concierge medical model.

Prescription-only product. Intended to support normal hormonal, metabolic, and physiological function under the supervision of a qualified healthcare professional. Not intended to diagnose, treat, cure, or prevent any disease.